A detailed history of First Financial Corp transactions in Novo Nordisk A S stock. As of the latest transaction made, First Financial Corp holds 6,470 shares of NVO stock, worth $676,503. This represents 0.37% of its overall portfolio holdings.

Number of Shares
6,470
Previous 6,550 1.22%
Holding current value
$676,503
Previous $934,000 17.56%
% of portfolio
0.37%
Previous 0.48%

Shares

4 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 24, 2024

SELL
$119.07 - $145.42 $9,525 - $11,633
-80 Reduced 1.22%
6,470 $770,000
Q4 2023

Jan 16, 2024

BUY
$87.78 - $105.45 $10,358 - $12,443
118 Added 1.83%
6,550 $677,000
Q3 2023

Oct 11, 2023

BUY
$90.94 - $199.54 $584,926 - $1.28 Million
6,432 New
6,432 $584,000
Q3 2022

Oct 20, 2022

BUY
$95.28 - $116.93 $476 - $584
5 New
5 $0

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $236B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track First Financial Corp Portfolio

Follow First Financial Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of First Financial Corp , based on Form 13F filings with the SEC.

News

Stay updated on First Financial Corp with notifications on news.